Results 201 to 210 of about 98,067 (262)

Therapeutic Potential of Berberis vulgaris in Modulating Metabolic Syndrome Biomarkers: Mechanistic Insights and Functional Food Implications

Food Frontiers, Volume 7, Issue 4, July 2026.
ABSTRACT Barberry (Berberis vulgaris) has emerged as a promising functional food candidate for the management of metabolic syndrome due to its diverse bioactive constituents, particularly berberine. This review synthesizes current experimental and clinical evidence regarding its effects on glycemic control, lipid metabolism, blood pressure regulation ...
Fakhar Shahid, Ifrah Jabeen, Muhammad Inam‐ur‐Raheem, Amin Mousavi Khaneghah, Muhammad Abid, Rana Muhammad Aadil   +5 more
wiley   +1 more source

Periodontopathogens degrade angiotensin I from the human renin-angiotensin system through surface-attached proteases. [PDF]

Sci Rep
Waligórska I, Żak KM, Mikrut N, Budziaszek J, Medviediev V, Bielecka E, Kantyka T, Kozieł J, Thøgersen IB, Enghild JJ, Grudnik P, Potempa J, Książek M.   +12 more
europepmc   +1 more source

Fecal Proteomics Suggest Potential Biomarkers for Non‐Alcoholic Fatty Liver Disease and Steatohepatitis

PROTEOMICS – Clinical Applications, Volume 20, Issue 4, July 2026.
ABSTRACT Background and aims Non‐alcoholic Fatty Liver Disease (NAFLD) affects about a quarter of the world's population. Liver biopsy remains the gold standard for diagnosing the progressive form of NAFLD called Non‐alcoholic Steatohepatitis (NASH) but it is invasive, prone to sampling errors and observer variability, and impractical for widespread ...
Anna Negroni, Luisa Pieroni, Noemi Fiaschini, Francesca Palone, Mariateresa Mancuso, Roberta Vitali   +5 more
wiley   +1 more source

Prognostic Impact of Renin-Angiotensin System Inhibitors in Revascularized Patients with Acute Myocardial Infarction and Preserved or Mildly Reduced Ejection Fraction: A Retrospective Cohort Study. [PDF]

J Clin Med
Yang Y, Liao M, Liu X, Jian Z, Chen L, Yao Y, Yuan Z, Guo S.   +7 more
europepmc   +1 more source

Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6022-6033, July 2026.
ABSTRACT Aims The American Diabetes Association recommends achieving treatment goals (glycated haemoglobin ≤ 53 mmol/mol [7.0%], blood pressure < 130/80 mmHg, low‐density lipoprotein cholesterol < 1.81 mmol/L and use of sodium–glucose cotransporter‐2 inhibitors or glucagon‐like peptide‐1 receptor agonists), to reduce cardiovascular and kidney ...
João Sérgio Neves, Ana Rita Leite, Francisco Vasques‐Nóvoa, Bertram Pitt, Gerasimos Filippatos, Luis M. Ruilope, Peter Rossing, Stefan D. Anker, Gianluigi Savarese, Charlie A. B. Scott, Andrea Lage, Meike D. Brinker, João Pedro Ferreira   +12 more
wiley   +1 more source

β-Caryophyllene as a Novel Modulator of the Renin-Angiotensin System: A Path to Reduce Inflammation and Restore Taste Function. [PDF]

Biomedicines
López-Salido SC, Espinoza-Gutiérrez HA, Flores-Soto ME, Martínez-Preciado AH, Viveros-Paredes JM.   +4 more
europepmc   +1 more source

Repetitive transcranial magnetic stimulation ameliorates myocardial injury in vascular dementia via renin-angiotensin system modulation. [PDF]

Neuroreport
Li J, Su J, Zhu B, Gao X.
europepmc   +1 more source

Deep learning-driven proteomics analysis for gene annotation in the renin-angiotensin system. [PDF]

Eur J Pharmacol
Eivazi M, Hosseini K, Alipanahi S, Xia H, Restivo L, Patel A, Gozali M, Ebrahimi T, Scarborough A, Tarhriz V, Lazartigues E.   +10 more
europepmc   +1 more source

A comparison of drugs targeting the renin-angiotensin system and global cognition in aging. [PDF]

J Alzheimers Dis
George CJ, Kyaw KT, Hall CB, Weiss EF, Verghese J, Abadir P.   +5 more
europepmc   +1 more source